Dudediligence.

Mangoceuticals, Inc

MGRXNASDAQ · Services-Misc Health & Allied Services, NEC
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$133,368Sep ’24$105,247Dec ’24$109,306Mar ’25$168,109Jun ’25$84,246Sep ’25$94,360Dec ’25$67,864Mar ’26$68,757Jun ’26
Net income, by quarter
−$2.0MSep ’24−$1.9MDec ’24−$4.8MMar ’25−$5.4MJun ’25−$7.6MSep ’25−$2.8MDec ’25−$3.4MMar ’26−$1.3MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenue$8,939$731,493$615,873$456,021
Gross profit$4,850$431,501$379,964$250,386
Operating income−$2.0M−$9.2M−$8.0M−$18.0M
Net income−$2.0M−$9.2M−$8.7M−$20.6M
Operating cash flow−$1.3M−$7.0M−$4.9M−$5.9M
Free cash flow−$1.4M−$7.0Mnone on filenone on file
Cash$682,860$739,006$58,653$1.5M
Shares outstanding13.4M1.4M3.2M15.9M